tDCS + Cognitive Training for Alcoholism
(tDCS/AUD Trial)
Trial Summary
What is the purpose of this trial?
Alcohol misuse is an epidemic among Veterans in the United States. Nearly 1/3 of Veterans have a lifetime history of Alcohol Use Disorder (AUD). In 2014, there were 15,306 unique patients treated in inpatient VA treatment programs alone, which represents a 10.7% increase from just two years prior. Unfortunately, about 2/3 of those entering treatment will relapse within one year. Cognitive impairments found in chronic alcohol use interfere with adaptive behavior needed for successful recovery. These cognitive impairments and their underlying neural substrates may provide promising new targets for interventions that can reduce relapse rates. Evidence suggests that cognitive training can improve cognition in individuals with AUD, strengthen neural networks mediating cognition, and improve treatment outcome. However, cognitive training is effort intensive, has small effect sizes, and may have limited durability. The primary objective of this study is to investigate if transcranial direct current stimulation (tDCS) can increase the effectiveness of cognitive training to enhance cognition in alcohol use disorder and improve treatment outcome.
Will I have to stop taking my current medications?
The trial requires that you have been on a stable dose of all your medications (except for as-needed medications) for at least 30 days before starting. So, you won't need to stop your current medications, but they should be stable.
What data supports the effectiveness of the treatment tDCS + Cognitive Training for Alcoholism?
Research shows that transcranial direct current stimulation (tDCS) can reduce alcohol cravings and relapse rates in people with alcohol use disorder. Additionally, cognitive training has been found to help improve cognitive processes in those with alcohol dependence, suggesting that combining these treatments could be beneficial.12345
Is transcranial direct current stimulation (tDCS) safe for humans?
Transcranial direct current stimulation (tDCS) is generally well tolerated in humans, with studies showing no significant adverse events reported during trials for alcohol use disorder. It is considered a non-invasive brain stimulation technique that has been used safely in various clinical settings.23467
How does the tDCS + Cognitive Training treatment for alcoholism differ from other treatments?
The tDCS + Cognitive Training treatment is unique because it combines brain stimulation (tDCS) with cognitive exercises to enhance brain plasticity and improve outcomes for alcohol dependence. This approach is different from traditional treatments as it directly targets brain function and cognitive processes, potentially reducing cravings and relapse rates.23489
Research Team
Kelvin O Lim, MD
Principal Investigator
Minneapolis VA Health Care System, Minneapolis, MN
Eligibility Criteria
This trial is for Veterans aged 22-65 with Alcohol Use Disorder who are receiving outpatient care and have been sober for at least a week. They must be able to consent, not in acute withdrawal, on stable medication doses, and without significant risks from participating or conditions that could affect the study's integrity.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 sessions of cognitive training concurrent with either sham or active tDCS
Follow-up
Participants are monitored for changes in binge drinking days, frontal-striatal functional connectivity, and cognitive test scores
Treatment Details
Interventions
- Active Transcranial Direct Current Stimulation (tDCS)
- Cognitive Training
- Sham Transcranial Direct Current Stimulation (tDCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
University of Minnesota
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator